Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
ANIX Stock — Anixa Biosciences Inc
Anixa Biosciences Inc (ANIX)
Updated November 9, 2026.
ANIX is a stock. Total return is -94.0% over the past 42 years.
Anixa Biosciences is a biotechnology company developing therapies and vaccines focused on cancer treatment, including a novel CAR-T cell therapy for ovarian cancer and vaccine candidates targeting breast cancer and other solid tumors. The company does not currently distribute to shareholders. This security appeals to investors seeking exposure to early-stage oncology development with a tolerance for biotechnology risk and no expectation of current income.
ANIX performance
Total return is -94.0% over the past 42 years. Over the past year its total return — price change plus distributions reinvested — is -24.6%. Its deepest 1-year drawdown was 55.0%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | 9.0% | — |
| 3M | -7.6% | — |
| 6M | 5.3% | — |
| YTD | 1.3% | — |
| 1Y | -24.6% | — |
| 2Y CAGR | — | -4.10% |
| 3Y CAGR | — | 3.00% |
| 5Y CAGR | — | -8.50% |
| 10Y CAGR | — | -5.80% |
| Since inception 1984-11-05 · 42 years | -94.0% | -6.50% |
ANIX key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 11/05/1984
- Distribution frequency
- None
- Last close
- $3.16 (as of 2026-11-09)
- Market cap
- $109,853,614
- Average volume
- 126,713
- Beta
- 0.476
- Payout ratio
- 0.0%
- EPS
- -$0.33
How Dividend Vision calculates returns
Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
ANIX risks and drawbacks
The deepest 1-year drawdown on record here is 55.0%.
Who may consider ANIX — and who may not
It is a weaker fit for investors who need monthly cash flow (ANIX does not currently distribute). This is educational context, not a recommendation to buy or sell.
More on ANIX
Frequently asked questions
Does ANIX pay monthly?
No. ANIX does not currently distribute.
When does ANIX pay a dividend?
ANIX does not currently distribute.
How has ANIX performed?
Total return is -94.0% over the past 42 years. Over the past year its total return — price change plus distributions reinvested — is -24.6%. Its deepest 1-year drawdown was 55.0%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.